By Aaron J.Burstein & Alysa Z. Hutnik, Kelley Drye
On April 27, 2023, Governor Jay Inslee signed into law the My Health My Data Act (MHMD), which will become effective on March 31, 2024. While the 2023 state legislative season may see the addition of four comprehensive privacy laws (Iowa, Indiana, Montana, and Tennessee), Washington’s State’s My Health My Data bill (HB 1155) could have the most far-reaching impact on businesses.
Although limited to “consumer health data,” MHMD’s actual scope is much broader than many might anticipate based on the title of the law. It imposes stringent notice, consent, and HIPAA-style authorizations to the collection, sharing, and sale of “consumer health data,” a term that captures a potentially vast array of data. MHMD also creates a private right of action, allowing consumers to bring claims under Washington’s Consumer Protection Act, in addition to authorizing enforcement by the state attorney general.
MHMD also fits a broader trend toward intense scrutiny of health information practices under state privacy laws, through FTC enforcement actions, and in private class actions.
This post takes a look at some of the key requirements and open questions under MHMD, and offers a few tips to help stay ahead of increasingly strict health privacy regulations.
MHMD’s Broad Scope
- “Consumers” and “Consumer Health Data.” “Consumers” under MHMD are Washington residents “in an individual or household context.” MHMD expressly excludes individuals in an employment context (but not expressly in a business-to-business context).
Significantly, the definition of “consumer” also includes “a natural person whose consumer health data is collected in Washington.” “Collection,” in turn, includes inferring, deriving, buying, acquiring, “or otherwise process[ing]” consumer health data. Similar to the CCPA, GDPR, and other privacy laws, MHMD defines “processing” to include “any operation or set of operations performed on consumer health data.” This provision makes the definitions of “consumer” and “consumer health data” circular, and it raises the question of whether MHMD applies to health data about individuals who reside outside of Washington. The final Senate report summarizes member comments suggesting that the intent of this definition is to cover non-residents who travel to Washington to obtain health care. The MHMD text, however, is not clearly limited to this circumstance.
Featured News
Judge Appoints Law Firms to Lead Consumer Antitrust Litigation Against Apple
Dec 22, 2024 by
CPI
Epic Health Systems Seeks Dismissal of Antitrust Suit Filed by Particle Health
Dec 22, 2024 by
CPI
Qualcomm Secures Partial Victory in Licensing Dispute with Arm, Jury Splits on Key Issues
Dec 22, 2024 by
CPI
Google Proposes Revised Revenue-Sharing Limits Amid Antitrust Battle
Dec 22, 2024 by
CPI
Japan’s Antitrust Authority Expected to Sanction Google Over Monopoly Practices
Dec 22, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand